Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buventol and Bufomix Easyhalers in Methacholine Challenge
NCT05084222Phase 4Completed
- Sponsor
- Orion Corporation
- Start
- Nov 2021
- Primary completion
- Jun 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of Buventol Easyhaler, budesonide + formoterol in asthma, sponsored by Orion Corporation. Started Nov 2021; status: completed.
02
Drugs
Buventol Easyhalerbudesonide + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT05084222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05084222.